Newsletter | May 26, 2023

05.26.23 -- Clinical Manufacturing Market Outlook

New Podcast Episode
Featured Articles
Clinical Manufacturing Market Outlook

In ISR’s Clinical Manufacturing Market Outlook report, we asked sponsors about their top reasons for being satisfied with an outsourced clinical trial manufacturing project.

Risky Business

Biopharma’s willingness to take big risks is evident in the dermatology therapeutic area, even as executives must continue managing through a shaky financial environment.

The State Of Biotech M&A In 2023

Notwithstanding the continuation of the macroeconomic and geopolitical headwinds faced in 2022 into 2023, many market observers remain optimistic that biotech M&A activity will rebound.


Web-Exclusive Content
AI-Driven Medtech Begins To Deliver On Its Potential

The successful use of artificial intelligence (AI) has been a long time coming. Today, more than 530 AI/ML-enabled medical devices have been authorized by the FDA. This article highlights some promising examples.

Industry Insights
Navigating NDA Submission, Plus A Resubmission Rescue Mission

This biopharmaceutical company had to overcome trial master file (TMF) transfer from a previous licensee, staff turnover, and then a resubmission of its NDA.

Digital Edition
May 2023 Digital Edition

Inside you will find more on:

  • New Ways To Tackle The Dermatology Market
  • CTIS Submissions
  • Securing Rare Disease Funding
  • Building It All In-House

View the digital edition.

Contribute To Life Science Leader
Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable?  Read these guidelines first before submitting your idea or your article to our editorial director.